Literature DB >> 10741401

Class I-restricted presentation of exogenous antigen acquired by Fcgamma receptor-mediated endocytosis is regulated in dendritic cells.

P Machy1, K Serre, L Leserman.   

Abstract

We evaluated MHC class I- and II-restricted presentation of exogenous antigen by mouse bone marrow-derived dendritic cells (DC) and splenic B cells. DC presented to class I-restricted transgenic T cells femtomolar concentrations of antigens from liposomes targeted to the IgG Fc receptor. Targeting these liposomes to surface immunoglobulin did not permit B cells to stimulate class I-restricted responses. Nevertheless, both DC and B cells presented antigen from liposomes targeted to these same receptors with equivalent efficiency to class II-restricted T cells. Acquisition of the capacity to present class II-restricted antigens required shorter periods of differentiation of DC than presentation of exogenous class I-restricted antigens. The latent period for class I-restricted presentation of exogenous antigen by DC could not be shortened by exposing them to lipopolysaccharide, double-stranded RNA or antibody to CD40. Class I presentation depended on expression of the TAP1 transporter. Our data are consistent with the existence of a regulated transport process present in DC which can convey exogenous antigen from endocytic vesicles to the cytosol.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10741401     DOI: 10.1002/1521-4141(200003)30:3<848::AID-IMMU848>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  31 in total

Review 1.  Cross-presentation: dendritic cells and macrophages bite off more than they can chew!

Authors:  Sven Brode; Paul A Macary
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

2.  Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants.

Authors:  Daniel Chargelegue; Pascal M W Drake; Patricia Obregon; Alessandra Prada; Neil Fairweather; Julian K-C Ma
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 3.  Applications of nanomaterials as vaccine adjuvants.

Authors:  Motao Zhu; Rongfu Wang; Guangjun Nie
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

Review 4.  Fc receptors as adaptive immunoreceptors.

Authors:  Marc Daëron
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

Review 5.  Role of Fc-FcγR interactions in the antitumor activity of therapeutic antibodies.

Authors:  Bryan C Barnhart; Michael Quigley
Journal:  Immunol Cell Biol       Date:  2016-12-15       Impact factor: 5.126

6.  Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells.

Authors:  Ying Qiu; Ming-Bao Xu; Mark M Yun; Yi-Zhong Wang; Rui-Ming Zhang; Xing-Kai Meng; Xiao-Hui Ou-Yang; Sheng Yun
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

7.  Phenotype and polarization of autologous T cells by biomaterial-treated dendritic cells.

Authors:  Jaehyung Park; Michael H Gerber; Julia E Babensee
Journal:  J Biomed Mater Res A       Date:  2014-03-25       Impact factor: 4.396

8.  Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo.

Authors:  Suzanne N Franki; Kristopher K Steward; David J Betting; Kamran Kafi; Reiko E Yamada; John M Timmerman
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

Review 9.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

Review 10.  Recent advancements in cytotoxic T lymphocyte generation methods using carbohydrate-coated liposomes.

Authors:  Yuzuru Ikehara; Masahiro Yamanaka; Takashi Yamaguchi
Journal:  J Biomed Biotechnol       Date:  2010-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.